IFRX logo

InflaRx NV (IFRX) Company Overview

Profile

Full Name:

InflaRx N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Germany

IPO:

November 7, 2017

Indexes:

Not included

Website:

http://www.inflarx.de

Description:

InflaRx NV is a biopharmaceutical company focused on developing innovative treatments for inflammatory diseases. Their main product candidates target the complement system, aiming to reduce inflammation and improve patient outcomes in conditions like hidradenitis suppurativa and other serious diseases.

Key Details

Price

$1.27

Market Cap

$74.68 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$68.30 K

Annual EPS

-$0.84(-19.50% YoY)

PE Ratio

-

Annual ROE

-44.39%

Annual Debt To Equity

0.00

Beta

0.52

Events Calendar

Earnings

Next earnings date:

Mar 20, 2025

Recent quarterly earnings:

Nov 8, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 16, 25 HC Wainwright & Co.
Buy
Dec 20, 24 HC Wainwright & Co.
Buy
Nov 15, 24 HC Wainwright & Co.
Buy
Nov 11, 24 HC Wainwright & Co.
Buy
Sep 25, 24 HC Wainwright & Co.
Buy
Jun 24, 24 HC Wainwright & Co.
Buy
Jun 6, 24 HC Wainwright & Co.
Buy
May 9, 24 HC Wainwright & Co.
Buy
Mar 22, 24 HC Wainwright & Co.
Buy
Jan 25, 24 HC Wainwright & Co.
Buy

Screeners with IFRX included

Healthcare sector
All stocks
Biotechnology industry
Small cap stocks
Stocks below SMA 200
NASDAQ earnings calendar
Stocks with low RSI

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.27
IFRX price is $1.27

Price All-time High

$51.61
IFRX price is currently -97.54% below its historical high of $51.61

Price Analysts Target

-
IFRX price consensus analysts' forecast is unknown

Price Most Recent Change

+3.11%
IFRX price was up +3.11% on Mar 5, 2025

Price YTD Change

-48.66%
IFRX price is down -48.66% since January 1st

Price 3-Year Change

-39.9%
IFRX price is down -39.9% over the past 3 years

Market cap

Market Cap

$74.68 M
IFRX market capitalization is $74.68 million

Market Cap 3-Year Change

-19.94%
IFRX market capitalization is down -19.94% over the past 3 years

Market Cap All-time High

$1.34 B
IFRX market capitalization is currently -94.43% below its historical high of $1.34 billion

Market Cap Sector Rank

41.73%
IFRX market capitalization is higher than 41.73% of companies in Healthcare sector

Technical

Beta

0.52
IFRX beta is 0.52

200-day SMA

$1.79
IFRX price is currently -29.18% below its 200-day simple moving average

14-day RSI

24.18
IFRX 14-day relative strength index is 24.18

30-day Relative Volume

1.13
IFRX 30-day relative volume is 1.13

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$68.30 K
IFRX annual revenue is $68.30 thousand

Annual Revenue Analysts Estimate

$283.25 K
IFRX annual revenue is currently -75.89% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-
IFRX annual revenue 1-year change is unknown

Annual Revenue Sector Rank

6.7%
IFRX annual revenue is higher than 6.7% of companies in Healthcare sector

Profit

Annual Gross Profit

-$507.90 K
IFRX annual gross profit is -$507.90 thousand

Annual Gross Margin

-743.67%
IFRX annual gross profit margin is -743.67%

Annual Operating Profit

-$48.62 M
IFRX annual operating income is -$48.62 million

Annual Operating Margin

-71.18 K%
IFRX annual operating profit margin is -71.18 thousand%

Annual Net Income

-$46.19 M
IFRX annual net profit is -$46.19 million

Annual Net Margin

-67.63 K%
IFRX annual net profit margin is -67.63 thousand%

EPS

Annual EPS

-$0.84
IFRX annual earnings per share is -$0.84

Annual EPS Analysts Estimate

-$0.98
IFRX annual earnings per share is currently -13.84% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-19.5%
IFRX annual earnings per share is down -19.5% year-on-year

Annual EPS Sector Rank

61.74%
IFRX annual earnings per share is higher than 61.74% of companies in Healthcare sector

ROA & ROE

Annual ROA

-34.76%
IFRX annual return on assets is -34.76%

Annual ROE

-44.39%
IFRX annual return on equity is -44.39%

EBIT & EBITDA

Annual EBIT

-$46.15 M
IFRX annual earnings before interest & taxes is -$46.15 million

Annual EBITDA

-$45.54 M
IFRX annual EBITDA is -$45.54 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
IFRX price to earnings ratio value is unknown

PE Ratio Sector Rank

-
IFRX price to earnings ratio is unknown

PB Ratio

PB Ratio

1.02
IFRX price to book ratio is 1.02

PB Ratio Sector Rank

44.06%
IFRX price to book ratio is higher than 44.06% of companies in Healthcare sector

PS Ratio

PS Ratio

404.53
IFRX price to sales ratio is 404.53

PS Ratio Sector Rank

97.66%
IFRX price to sales ratio is higher than 97.66% of companies in Healthcare sector

Enterprise value

Enterprise Value

$46.41 M
IFRX enterprise value is $46.41 million

Enterprise Value Sector Rank

39.18%
IFRX enterprise value is higher than 39.18% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.76
IFRX EV/EBITDA is -0.76

EV/EBITDA Sector Rank

48.9%
IFRX EV/EBITDA is higher than 48.9% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

6.50
IFRX annual current ratio is 6.50

Annual Quick Ratio

5.82
IFRX annual quick ratio is 5.82

Leverage

Annual Debt To Equity

0.00
IFRX annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-1195.69
IFRX annual interest coverage ratio is -1195.69

Risk & Stability

Piotroski F-Score

4
IFRX piotroski f-score is 4

Altman Z-Score

-1.25
IFRX altman z-score is -1.25

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$132.88 M
IFRX annual total assets is $132.88 million

Annual Non Current Assets

$11.87 M
IFRX annual long term assets is $11.87 million

Annual Current Assets

$121.01 M
IFRX annual total current assets is $121.01 million

Annual Cash & Cash Equivalents

$14.11 M
IFRX annual cash & cash equivalents is $14.11 million

Equity

Annual Book Value

$113.39 M
IFRX annual book value is $113.39 million

Annual Working Capital

$102.39 M
IFRX annual working capital is $102.39 million

Liabilities

Annual Total Liabilities

$19.48 M
IFRX annual total liabilities is $19.48 million

Annual Total Long Term Liabilities

$865.10 K
IFRX annual total long term liabilities is $865.10 thousand

Annual Current Liabilities

$18.62 M
IFRX annual total current liabilities is $18.62 million

Annual Accounts Payable

$13.24 M
IFRX annual accounts payable is $13.24 million

Debt

Annual Total Debt

$1.24 M
IFRX annual total debt is $1.24 million

Annual Total Debt 1-Year Change

-14.9%
IFRX annual total debt is down -14.9% year-on-year

Annual Long Term Debt

$824.30 K
IFRX annual long term debt is $824.30 thousand

Annual Short Term Debt

$413.80 K
IFRX annual short term debt is $413.80 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$48.69 M
IFRX annual total expenses is $48.69 million

Annual Operating Expenses

$48.11 M
IFRX annual total operating expenses is $48.11 million

Annual Cost Of Goods Sold

$576.20 K
IFRX annual cost of goods sold is $576.20 thousand

Annual SGA

$17.45 M
IFRX annual SGA is $17.45 million

Annual D&A

$614.70 K
IFRX annual depreciation & amortization is $614.70 thousand

Annual Interest Expense

$38.60 K
IFRX annual interest expense is $38.60 thousand

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$40.94 M
IFRX annual cash flow from operations is -$40.94 million

Annual CFO 1-Year Change

-15.04%
IFRX annual cash flow from operations is down -15.04% year-on-year

Annual CFI

-$19.16 M
IFRX annual cash flow from investing activities is -$19.16 million

Annual CFI 1-Year Change

-193.85%
IFRX annual cash flow from investing activities is down -193.85% year-on-year

Annual CFF

$57.36 M
IFRX annual cash flow from financing activities is $57.36 million

Annual CFF 1-Year Change

+2707.53%
IFRX annual cash flow from financing activities is up +2707.53% year-on-year

Free CashFlow

Annual FCF

-$41.02 M
IFRX annual free cash flow is -$41.02 million

Annual FCF 1-Year Change

-14.73%
IFRX annual free cash flow is down -14.73% year-on-year

CAPEX

Annual CAPEX

$87.80 K
IFRX annual capital expenditures is $87.80 thousand

Annual CAPEX 1-Year Change

-
IFRX annual capital expenditures 1-year change is unknown

Institutional Ownership

Similar stocks

GNTA logo
Genenta Science SpA (GNTA)
ABOS logo
Acumen Pharmaceuticals (ABOS)
Citius Oncology (CTOR)
EPIX logo
ESSA Pharma (EPIX)
TARA logo
Protara Therapeutics (TARA)
ENTX logo
Entera Bio (ENTX)
NSPR logo
InspireMD (NSPR)
XTNT logo
Xtant Medical Holdings (XTNT)
INCR logo
InterCure (INCR)

FAQ

  • What is the ticker symbol for InflaRx NV?
  • Does InflaRx NV pay dividends?
  • What sector is InflaRx NV in?
  • What industry is InflaRx NV in?
  • What country is InflaRx NV based in?
  • When did InflaRx NV go public?
  • Is InflaRx NV in the S&P 500?
  • Is InflaRx NV in the NASDAQ 100?
  • Is InflaRx NV in the Dow Jones?
  • When was InflaRx NV's last earnings report?
  • When does InflaRx NV report earnings?

What is the ticker symbol for InflaRx NV?

The ticker symbol for InflaRx NV is NASDAQ:IFRX

Does InflaRx NV pay dividends?

No, InflaRx NV does not pay dividends

What sector is InflaRx NV in?

InflaRx NV is in the Healthcare sector

What industry is InflaRx NV in?

InflaRx NV is in the Biotechnology industry

What country is InflaRx NV based in?

InflaRx NV is headquartered in Germany

When did InflaRx NV go public?

InflaRx NV's initial public offering (IPO) was on November 7, 2017

Is InflaRx NV in the S&P 500?

No, InflaRx NV is not included in the S&P 500 index

Is InflaRx NV in the NASDAQ 100?

No, InflaRx NV is not included in the NASDAQ 100 index

Is InflaRx NV in the Dow Jones?

No, InflaRx NV is not included in the Dow Jones index

When was InflaRx NV's last earnings report?

InflaRx NV's most recent earnings report was on Nov 8, 2024

When does InflaRx NV report earnings?

The next expected earnings date for InflaRx NV is Mar 20, 2025